Loading...
NOVA1 antibody

22767

NOVA1 antibody

NOVA1 antibody (catalogue number 22767) is a rabbit-derived primary antibody validated for WB IF, reactive with Human samples. It targets RNA-binding protein Nova-1 (NOVA1): RNA-binding protein which regulates alternative splicing of pre-mRNAs in the brain and spinal cord in a sequence-specific manner. Supplied as 100ul at ₪1,953.80; the final price is confirmed on your quote and the lot certificate of analysis ships with the order.

Primary AntibodyHostRabbit
Host / source
Rabbit
Reactivity
Human
Applications
WB IF
UniProt ID
P51513
Gene
NOVA1
Target organism
Homo sapiens
Catalogue number
22767
Brand
LABO Scientific
Storage
Store at -20°C for long term preservation (recommended). Store at 4°C for short term use.

Target background

Target: RNA-binding protein Nova-1 (NOVA1) · Homo sapiens

RNA-binding protein which regulates alternative splicing of pre-mRNAs in the brain and spinal cord in a sequence-specific manner. Binds to 5'-YCAY-3' repeats, with a minimum of 2 to 3 repeats necessary for high-affinity binding. Mediates both exon inclusion and exclusion, depending upon the position of its binding site within the pre-mRNA. Binding to 5'-YCAY-3' clusters results in a local and asymmetric action to regulate spliceosome assembly.

Subcellular location: Nucleus

Tissue specificity: Expressed in cerebellum, brain stem, hippocampus, and frontal cortex

Sequence length: 507 aa · 51727 Da

Protein background from UniProtKB, licensed under CC BY 4.0. Describes the target antigen, not this product.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Storage
Store at -20°C for long term preservation (recommended). Store at 4°C for short term use.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.